Skip to main content
Erschienen in: Medical Oncology 9/2014

01.09.2014 | Original Paper

The relationship between genetic variants of XRCC1 gene and lung cancer susceptibility in Chinese Han population

verfasst von: Jun Tang, Jianzhu Zhao, Jungang Zhao

Erschienen in: Medical Oncology | Ausgabe 9/2014

Einloggen, um Zugang zu erhalten

Abstract

Previous evidence indicate that genetic variants of X-ray repair cross-complementing group 1 gene (XRCC1) are potentially associated with the development of lung cancer. This study aimed to detect the relationship between the XRCC1 genetic variants and lung cancer susceptibility. A total of 420 lung cancer patients and 425 cancer-free healthy controls were recruited in this case–control study. The genotypes of XRCC1 genetic variants were investigated by the polymerase chain reaction–restriction fragment length polymorphism (PCR–RFLP). The relationship between the XRCC1 genetic variants and lung cancer susceptibility was determined by the association analyses. We found that the distributions of allelic and genotypic in lung cancer patients were significantly different from those of cancer-free healthy controls. Our data indicated that the XRCC1 c.1161G>A and c.1779C>G genetic variants were significantly associated with the increased susceptibility to lung cancer [for c.1161G>A, AA versus (vs.) GG: odds ratio (OR) 2.59, 95 % confidence interval (95 % CI) 1.59–4.21, χ 2 = 15.17, P < 0.001; A vs. G: OR 1.39, 95 % CI 1.13–1.70, P = 0.002; for c.1779C>G, GG vs. CC: OR 2.51, 95 % CI 1.42–4.44, χ 2 = 10.60, P = 0.001; G vs. C: OR 1.24, 95 % CI 1.00–1.54, χ 2 = 3.98, P = 0.046]. The allele A and genotype AA of c.1161G>A and allele G and genotype GG of c.1779C>G genetic variants may enhance lung cancer susceptibility. Taken together, these findings show that the functional c.1161G>A and c.1779C>G genetic variants of XRCC1 are associated with lung cancer susceptibility in the Chinese Han populations and might be used as molecular markers for evaluating the risk of lung cancer.
Literatur
1.
Zurück zum Zitat Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.PubMedCrossRef Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.PubMedCrossRef
2.
Zurück zum Zitat Cui Z, Yin Z, Li X, Wu W, Guan P, Zhou B. Association between polymorphisms in XRCC1 gene and clinical outcomes of patients with lung cancer: a meta-analysis. BMC Cancer. 2012;12:71.PubMedCrossRefPubMedCentral Cui Z, Yin Z, Li X, Wu W, Guan P, Zhou B. Association between polymorphisms in XRCC1 gene and clinical outcomes of patients with lung cancer: a meta-analysis. BMC Cancer. 2012;12:71.PubMedCrossRefPubMedCentral
3.
Zurück zum Zitat Yin Z, Zhou B, He Q, Li M, Guan P, Li X, Cui Z, Xue X, Su M, Ma R, Bai W, Xia S, Jiang Y, Xu S, Lv Y. Association between polymorphisms in DNA repair genes and survival of non-smoking female patients with lung adenocarcinoma. BMC Cancer. 2009;9:439.PubMedCrossRefPubMedCentral Yin Z, Zhou B, He Q, Li M, Guan P, Li X, Cui Z, Xue X, Su M, Ma R, Bai W, Xia S, Jiang Y, Xu S, Lv Y. Association between polymorphisms in DNA repair genes and survival of non-smoking female patients with lung adenocarcinoma. BMC Cancer. 2009;9:439.PubMedCrossRefPubMedCentral
4.
5.
6.
Zurück zum Zitat Guilbert JJ. The world health report 2002—reducing risks, promoting healthy life. Educ Health (Abingdon). 2003;16:230.CrossRef Guilbert JJ. The world health report 2002—reducing risks, promoting healthy life. Educ Health (Abingdon). 2003;16:230.CrossRef
7.
Zurück zum Zitat Viktorsson K, De Petris L, Lewensohn R. The role of p53 in treatment responses of lung cancer. Biochem Biophys Res Commun. 2005;331:868–80.PubMedCrossRef Viktorsson K, De Petris L, Lewensohn R. The role of p53 in treatment responses of lung cancer. Biochem Biophys Res Commun. 2005;331:868–80.PubMedCrossRef
8.
Zurück zum Zitat Karkucak M, Yakut T, Evrensel T, Deligonul A, Gulten T, Ocakoglu G, Kurt E, Kanat O, Cubukcu E, Sehitoglu I, Canhoroz M. XRCC1 gene polymorphisms and risk of lung cancer in Turkish patients. Int J Hum Genet. 2012;2:113–7. Karkucak M, Yakut T, Evrensel T, Deligonul A, Gulten T, Ocakoglu G, Kurt E, Kanat O, Cubukcu E, Sehitoglu I, Canhoroz M. XRCC1 gene polymorphisms and risk of lung cancer in Turkish patients. Int J Hum Genet. 2012;2:113–7.
9.
Zurück zum Zitat Qian B, Zhang H, Zhang L, Zhou X, Yu H, Chen K. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk. Lung Cancer. 2011;73:138–46.PubMedCrossRef Qian B, Zhang H, Zhang L, Zhou X, Yu H, Chen K. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk. Lung Cancer. 2011;73:138–46.PubMedCrossRef
10.
Zurück zum Zitat Sreeja L, Syamala VS, Syamala V, Hariharan S, Raveendran PB, Vijayalekshmi RV, Madhavan J, Ankathil R. Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India. J Cancer Res Clin Oncol. 2008;134:645–52.PubMedCrossRef Sreeja L, Syamala VS, Syamala V, Hariharan S, Raveendran PB, Vijayalekshmi RV, Madhavan J, Ankathil R. Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India. J Cancer Res Clin Oncol. 2008;134:645–52.PubMedCrossRef
11.
Zurück zum Zitat Lopez-Cima MF, Gonzalez-Arriaga P, Garcia-Castro L, Pascual T, Marron MG, Puente XS, Tardon A. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain. BMC Cancer. 2007;7:162.PubMedCrossRef Lopez-Cima MF, Gonzalez-Arriaga P, Garcia-Castro L, Pascual T, Marron MG, Puente XS, Tardon A. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain. BMC Cancer. 2007;7:162.PubMedCrossRef
12.
Zurück zum Zitat Giachino DF, Ghio P, Regazzoni S, Mandrile G, Novello S, Selvaggi G, Gregori D, DeMarchi M, Scagliotti GV. Prospective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer. Clin Cancer Res. 2007;13:2876–81.PubMedCrossRef Giachino DF, Ghio P, Regazzoni S, Mandrile G, Novello S, Selvaggi G, Gregori D, DeMarchi M, Scagliotti GV. Prospective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer. Clin Cancer Res. 2007;13:2876–81.PubMedCrossRef
13.
Zurück zum Zitat Chen J, Zhao QW, Shi GM, Wang LR. XRCC1 Arg399Gln and clinical outcome of platinum-based treatment for advanced non-small cell lung cancer: a meta-analysis in 17 studies. J Zhejiang Univ Sci B. 2012;13:875–83.PubMedCrossRefPubMedCentral Chen J, Zhao QW, Shi GM, Wang LR. XRCC1 Arg399Gln and clinical outcome of platinum-based treatment for advanced non-small cell lung cancer: a meta-analysis in 17 studies. J Zhejiang Univ Sci B. 2012;13:875–83.PubMedCrossRefPubMedCentral
14.
Zurück zum Zitat Guo S, Li X, Gao M, Li Y, Song B, Niu W. The relationship between XRCC1 and XRCC3 gene polymorphisms and lung cancer risk in northeastern Chinese. PLoS ONE. 2013;8:e56213.PubMedCrossRefPubMedCentral Guo S, Li X, Gao M, Li Y, Song B, Niu W. The relationship between XRCC1 and XRCC3 gene polymorphisms and lung cancer risk in northeastern Chinese. PLoS ONE. 2013;8:e56213.PubMedCrossRefPubMedCentral
15.
Zurück zum Zitat Hao B, Miao X, Li Y, Zhang X, Sun T, Liang G, Zhao Y, Zhou Y, Wang H, Chen X, Zhang L, Tan W, Wei Q, Lin D, He F. A novel T-77C polymorphism in DNA repair gene XRCC1 contributes to diminished promoter activity and increased risk of non-small cell lung cancer. Oncogene. 2006;25:3613–20.PubMedCrossRef Hao B, Miao X, Li Y, Zhang X, Sun T, Liang G, Zhao Y, Zhou Y, Wang H, Chen X, Zhang L, Tan W, Wei Q, Lin D, He F. A novel T-77C polymorphism in DNA repair gene XRCC1 contributes to diminished promoter activity and increased risk of non-small cell lung cancer. Oncogene. 2006;25:3613–20.PubMedCrossRef
16.
Zurück zum Zitat Yin J, Vogel U, Ma Y, Qi R, Wang H. Association of DNA repair gene XRCC1 and lung cancer susceptibility among nonsmoking Chinese women. Cancer Genet Cytogenet. 2009;188:26–31.PubMedCrossRef Yin J, Vogel U, Ma Y, Qi R, Wang H. Association of DNA repair gene XRCC1 and lung cancer susceptibility among nonsmoking Chinese women. Cancer Genet Cytogenet. 2009;188:26–31.PubMedCrossRef
17.
Zurück zum Zitat Kalikaki A, Kanaki M, Vassalou H, Souglakos J, Voutsina A, Georgoulias V, Mavroudis D. DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer. Clin Lung Cancer. 2009;10:118–23.PubMedCrossRef Kalikaki A, Kanaki M, Vassalou H, Souglakos J, Voutsina A, Georgoulias V, Mavroudis D. DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer. Clin Lung Cancer. 2009;10:118–23.PubMedCrossRef
18.
Zurück zum Zitat Chang JS, Wrensch MR, Hansen HM, Sison JD, Aldrich MC, Quesenberry CP Jr, Seldin MF, Kelsey KT, Wiencke JK. Base excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African-Americans. Carcinogenesis. 2009;30:78–87.PubMedCrossRefPubMedCentral Chang JS, Wrensch MR, Hansen HM, Sison JD, Aldrich MC, Quesenberry CP Jr, Seldin MF, Kelsey KT, Wiencke JK. Base excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African-Americans. Carcinogenesis. 2009;30:78–87.PubMedCrossRefPubMedCentral
19.
Zurück zum Zitat Butkiewicz D, Rusin M, Sikora B, Lach A, Chorazy M. An association between DNA repair gene polymorphisms and survival in patients with resected non-small cell lung cancer. Mol Biol Rep. 2011;38:5231–41.PubMedCrossRef Butkiewicz D, Rusin M, Sikora B, Lach A, Chorazy M. An association between DNA repair gene polymorphisms and survival in patients with resected non-small cell lung cancer. Mol Biol Rep. 2011;38:5231–41.PubMedCrossRef
20.
Zurück zum Zitat Li Y, Huang XE, Jin GF, Shen HB, Xu L. Lack of any relationship between chemotherapy toxicity in non-small cell lung cancer cases and polymorphisms in XRCC1 codon 399 or XPD codon 751. Asian Pac J Cancer Prev. 2011;12:739–42.PubMed Li Y, Huang XE, Jin GF, Shen HB, Xu L. Lack of any relationship between chemotherapy toxicity in non-small cell lung cancer cases and polymorphisms in XRCC1 codon 399 or XPD codon 751. Asian Pac J Cancer Prev. 2011;12:739–42.PubMed
21.
Zurück zum Zitat Wang Y, Yang H, Li H, Li L, Wang H, Liu C, Zheng Y. Association between X-ray repair cross complementing group 1 codon 399 and 194 polymorphisms and lung cancer risk: a meta-analysis. Cancer Lett. 2009;285:134–40.PubMedCrossRef Wang Y, Yang H, Li H, Li L, Wang H, Liu C, Zheng Y. Association between X-ray repair cross complementing group 1 codon 399 and 194 polymorphisms and lung cancer risk: a meta-analysis. Cancer Lett. 2009;285:134–40.PubMedCrossRef
22.
Zurück zum Zitat Huang G, Cai S, Wang W, Zhang Q, Liu A. Association between XRCC1 and XRCC3 polymorphisms with lung cancer risk: a meta-analysis from case-control studies. PLoS ONE. 2013;8:e68457.PubMedCrossRefPubMedCentral Huang G, Cai S, Wang W, Zhang Q, Liu A. Association between XRCC1 and XRCC3 polymorphisms with lung cancer risk: a meta-analysis from case-control studies. PLoS ONE. 2013;8:e68457.PubMedCrossRefPubMedCentral
23.
Zurück zum Zitat Letkova L, Matakova T, Musak L, Sarlinova M, Krutakova M, Slovakova P, Kavcova E, Jakusova V, Janickova M, Drgova A, Berzinec P, Halasova E. DNA repair genes polymorphism and lung cancer risk with the emphasis to sex differences. Mol Biol Rep. 2013;40:5261–73.PubMedCrossRef Letkova L, Matakova T, Musak L, Sarlinova M, Krutakova M, Slovakova P, Kavcova E, Jakusova V, Janickova M, Drgova A, Berzinec P, Halasova E. DNA repair genes polymorphism and lung cancer risk with the emphasis to sex differences. Mol Biol Rep. 2013;40:5261–73.PubMedCrossRef
24.
Zurück zum Zitat Li Y, Huang Y, Cao YS, Zeng J, Tong WN, Xu SL, Zhuo AS. Assessment of the association between XRCC1 Arg399Gln polymorphism and lung cancer in Chinese. Tumour Biol. 2013;34:3681–5. Li Y, Huang Y, Cao YS, Zeng J, Tong WN, Xu SL, Zhuo AS. Assessment of the association between XRCC1 Arg399Gln polymorphism and lung cancer in Chinese. Tumour Biol. 2013;34:3681–5.
25.
Zurück zum Zitat Li W, Li K, Zhao L, Zou H. DNA repair pathway genes and lung cancer susceptibility: a meta-analysis. Gene. 2014;538:361–5. Li W, Li K, Zhao L, Zou H. DNA repair pathway genes and lung cancer susceptibility: a meta-analysis. Gene. 2014;538:361–5.
26.
Zurück zum Zitat Rybarova S, Hodorova I, Muri J, Mihalik J, Adamkov M, Svajdler M, Piovarci D, Mirossay L. Prognostic significance of p53 protein and X-ray repair cross-complementing protein 1 in non-small cell lung cancer. Tumori. 2011;97:79–85.PubMed Rybarova S, Hodorova I, Muri J, Mihalik J, Adamkov M, Svajdler M, Piovarci D, Mirossay L. Prognostic significance of p53 protein and X-ray repair cross-complementing protein 1 in non-small cell lung cancer. Tumori. 2011;97:79–85.PubMed
27.
Zurück zum Zitat Perez-Morales R, Mendez-Ramirez I, Castro-Hernandez C, Martinez-Ramirez OC, Gonsebatt ME, Rubio J. Polymorphisms associated with the risk of lung cancer in a healthy Mexican Mestizo population: application of the additive model for cancer. Genet Mol Biol. 2011;34:546–52.PubMedCrossRefPubMedCentral Perez-Morales R, Mendez-Ramirez I, Castro-Hernandez C, Martinez-Ramirez OC, Gonsebatt ME, Rubio J. Polymorphisms associated with the risk of lung cancer in a healthy Mexican Mestizo population: application of the additive model for cancer. Genet Mol Biol. 2011;34:546–52.PubMedCrossRefPubMedCentral
28.
Zurück zum Zitat Natukula K, Jamil K, Pingali UR, Attili VS, Madireddy UR. The codon 399 Arg/Gln XRCC1 polymorphism is associated with lung cancer in Indians. Asian Pac J Cancer Prev. 2013;14:5275–9.PubMedCrossRef Natukula K, Jamil K, Pingali UR, Attili VS, Madireddy UR. The codon 399 Arg/Gln XRCC1 polymorphism is associated with lung cancer in Indians. Asian Pac J Cancer Prev. 2013;14:5275–9.PubMedCrossRef
29.
Zurück zum Zitat Sun Y, Zhang YJ, Kong XM. No association of XRCC1 and CLPTM1L polymorphisms with non-small cell lung cancer in a non-smoking Han Chinese population. Asian Pac J Cancer Prev. 2013;14:5171–4.PubMedCrossRef Sun Y, Zhang YJ, Kong XM. No association of XRCC1 and CLPTM1L polymorphisms with non-small cell lung cancer in a non-smoking Han Chinese population. Asian Pac J Cancer Prev. 2013;14:5171–4.PubMedCrossRef
30.
Zurück zum Zitat Guo QX, Yang WH, Zhai JF, Han FC, Wang CY. XRCC1 codon 280 polymorphism and susceptibility to lung cancer: a meta-analysis of the literatures. Tumour Biol. 2013;34:2989–94.PubMedCrossRef Guo QX, Yang WH, Zhai JF, Han FC, Wang CY. XRCC1 codon 280 polymorphism and susceptibility to lung cancer: a meta-analysis of the literatures. Tumour Biol. 2013;34:2989–94.PubMedCrossRef
31.
Zurück zum Zitat Ouyang FD, Yang FL, Chen HC, Khan MA, Huang FM, Wan XX, Xu AH, Huang X, Zhou MJ, Fang Q, Zhang DZ. Polymorphisms of DNA repair genes XPD, XRCC1, and OGG1, and lung adenocarcinoma susceptibility in Chinese population. Tumour Biol. 2013;34:2843–8.PubMedCrossRef Ouyang FD, Yang FL, Chen HC, Khan MA, Huang FM, Wan XX, Xu AH, Huang X, Zhou MJ, Fang Q, Zhang DZ. Polymorphisms of DNA repair genes XPD, XRCC1, and OGG1, and lung adenocarcinoma susceptibility in Chinese population. Tumour Biol. 2013;34:2843–8.PubMedCrossRef
32.
Zurück zum Zitat Wang JY, Cai Y. X-ray repair cross-complementing group 1 codon 399 polymorphism and lung cancer risk: an updated meta-analysis. Tumour Biol. 2014;35:411–8. Wang JY, Cai Y. X-ray repair cross-complementing group 1 codon 399 polymorphism and lung cancer risk: an updated meta-analysis. Tumour Biol. 2014;35:411–8.
33.
Zurück zum Zitat Wu T, Xu YH, Ye XL. X-ray repair cross-complementing group 1 Arg194Trp polymorphism is associated with increased risk of lung cancer in Chinese Han population. Tumour Biol. 2013;34:2611–5.PubMedCrossRef Wu T, Xu YH, Ye XL. X-ray repair cross-complementing group 1 Arg194Trp polymorphism is associated with increased risk of lung cancer in Chinese Han population. Tumour Biol. 2013;34:2611–5.PubMedCrossRef
34.
Zurück zum Zitat Li D, Zhou Q, Liu Y, Yang Y, Li Q. DNA repair gene polymorphism associated with sensitivity of lung cancer to therapy. Med Oncol. 2012;29:1622–8.PubMedCrossRef Li D, Zhou Q, Liu Y, Yang Y, Li Q. DNA repair gene polymorphism associated with sensitivity of lung cancer to therapy. Med Oncol. 2012;29:1622–8.PubMedCrossRef
35.
Zurück zum Zitat Ke HG, Li J, Shen Y, You QS, Yan Y, Dong HX, Liu JH, Shen ZY. Prognostic significance of GSTP1, XRCC1 and XRCC3 polymorphisms in non-small cell lung cancer patients. Asian Pac J Cancer Prev. 2012;13:4413–6.PubMedCrossRef Ke HG, Li J, Shen Y, You QS, Yan Y, Dong HX, Liu JH, Shen ZY. Prognostic significance of GSTP1, XRCC1 and XRCC3 polymorphisms in non-small cell lung cancer patients. Asian Pac J Cancer Prev. 2012;13:4413–6.PubMedCrossRef
36.
Zurück zum Zitat Dai L, Duan F, Wang P, Song C, Wang K, Zhang J. XRCC1 gene polymorphisms and lung cancer susceptibility: a meta-analysis of 44 case-control studies. Mol Biol Rep. 2012;39:9535–47.PubMedCrossRef Dai L, Duan F, Wang P, Song C, Wang K, Zhang J. XRCC1 gene polymorphisms and lung cancer susceptibility: a meta-analysis of 44 case-control studies. Mol Biol Rep. 2012;39:9535–47.PubMedCrossRef
37.
Zurück zum Zitat Huang J, Zhang J, Zhao Y, Liao B, Liu J, Li L, Liao M, Wang L. The Arg194Trp polymorphism in the XRCC1 gene and cancer risk in Chinese Mainland population: a meta-analysis. Mol Biol Rep. 2011;38:4565–73.PubMedCrossRef Huang J, Zhang J, Zhao Y, Liao B, Liu J, Li L, Liao M, Wang L. The Arg194Trp polymorphism in the XRCC1 gene and cancer risk in Chinese Mainland population: a meta-analysis. Mol Biol Rep. 2011;38:4565–73.PubMedCrossRef
38.
Zurück zum Zitat Zhang J, Zeng XT, Lei JR, Tang YJ, Yang J. No association between XRCC1 gene Arg194Trp polymorphism and risk of lung cancer: evidence based on an updated cumulative meta-analysis. Tumour Biol. 2014;35:5629–35. Zhang J, Zeng XT, Lei JR, Tang YJ, Yang J. No association between XRCC1 gene Arg194Trp polymorphism and risk of lung cancer: evidence based on an updated cumulative meta-analysis. Tumour Biol. 2014;35:5629–35.
39.
Zurück zum Zitat Wang R, Zhang Y, Zhang J, Zhi X. Association of X-ray repair cross-complementing group 1 promoter rs3213245 polymorphism with lung cancer risk. Tumour Biol. 2014;35:1739–43. Wang R, Zhang Y, Zhang J, Zhi X. Association of X-ray repair cross-complementing group 1 promoter rs3213245 polymorphism with lung cancer risk. Tumour Biol. 2014;35:1739–43.
40.
Zurück zum Zitat Daly AK, Steen VM, Fairbrother KS, Idle JR. CYP2D6 multiallelism. Methods Enzymol. 1996;272:199–210.PubMedCrossRef Daly AK, Steen VM, Fairbrother KS, Idle JR. CYP2D6 multiallelism. Methods Enzymol. 1996;272:199–210.PubMedCrossRef
41.
Zurück zum Zitat Wang L, Chen Z, Wang Y, Chang D, Su L, Guo Y, Liu C. The association of c.1471G>A genetic polymorphism in XRCC1 gene with lung cancer susceptibility in Chinese Han population. Tumour Biol. 2014;35:5389–93. Wang L, Chen Z, Wang Y, Chang D, Su L, Guo Y, Liu C. The association of c.1471G>A genetic polymorphism in XRCC1 gene with lung cancer susceptibility in Chinese Han population. Tumour Biol. 2014;35:5389–93.
Metadaten
Titel
The relationship between genetic variants of XRCC1 gene and lung cancer susceptibility in Chinese Han population
verfasst von
Jun Tang
Jianzhu Zhao
Jungang Zhao
Publikationsdatum
01.09.2014
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 9/2014
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-014-0157-7

Weitere Artikel der Ausgabe 9/2014

Medical Oncology 9/2014 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.